Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
bio
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
artificial intelligence
atomico vc
base editing
biogen
biome
biotech
blueprint medicineas
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
briefing docs
california
cancer
cancer diagnostics
car-t
celgene
cervical cancer
clinical study
clinical trial
commissioner
crispr
crispr therapeutics
cybersecurity
democrats
detection
detroit blog main
detroit top stories
digital health
disease
diversity
What
cancer
3
×
million
remains
3
×
investors
medical
years
according
allogene
announced
applied
atomico
attacks
bio
bioscience
breast
company
connect
consuming
counterpoint
crispr
detection
diagnosing
diagnosis
diagnostics
died
disease
diversity
early
existing
exor
expensive
focused
funds
globally
greycroft
health
history
hot
hoxton
human
Language
unset
Current search:
remains
×
cancer
×
@tech.eu
4 years ago
Kheiron’s $22 million Series A funds early breast cancer detection for women worldwide
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@techcrunch.com
6 years ago
Tradewind Bioscience attacks the physiology of tumors to treat cancer
